Historically good results with IL-4 inhibitors raise questions with U.S. audience ...

Patients with seborrheic dermatitis are at an increased risk of developing scarring alopecia compared with those without seborrheic dermatitis.

As the 2026 American Academy of Dermatology (AAD) annual meeting approaches, MedPage Today is offering a preview of an ...

Exposure to dupilumab is associated with an increased risk of being diagnosed with cutaneous autoimmune diseases in children ...

As the 2026 American Academy of Dermatology (AAD) annual meeting continues in Denver, MedPage Today is offering another ...

Patients with atopic dermatitis who receive treatment with dupilumab may be at an increased risk for new-onset vitiligo.

AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research sessionAcross the COAST 1, ...

New research links atopic dermatitis to S1P signalling pathways driving inflammation. Learn how this could shape future ...

Atopic dermatitis in childhood is not associated with increased early markers of cardiovascular risk, a study finds.

Investigational ZORYVE® (roflumilast) cream 0.05% was well tolerated with safety findings consistent with prior pediatric experience in the ...

Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a ...

Our highly trained dermatologists effectively diagnose and treat contact dermatitis in our clinic at University of Utah Health. Contact dermatitis is a skin disorder that occurs when a foreign ...